Delivery order in IV/IP chemotherapy administration
Oncology nurses are taught to always administer platinums before taxanes for IV chemotherapy regimens. Does this still hold true when the taxane is ordered IV, and the platinum is ordered IP? Also, when IV mannitol is ordered, can that be run concurrent with the IP platinum? —Cathy Ollom RN, BSN, OCN
When cisplatin is administered before paclitaxel, the beneficial effects of paclitaxel may be decreased. Administering cisplatin before paclitaxel may also change how the patient’s body processes paclitaxel, which can result in an increase in its toxic effects. This rule is primarily applicable to IV administration of both drugs. But IP administration changes the dynamics as IP drug delivery is delayed and sustained, so order of administration does not make much difference. Concurrent use of paclitaxel and mannitol is compatible. —Donald R. Fleming, MD
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.